+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COVID-19 Diagnostics Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2022

  • ID: 5125484
  • Report
  • September 2020
  • Region: Global
  • 275 Pages
  • Allied Analytics LLP
Global COVID-19 Diagnostics Market Anticipated to be Worth $17,203.38 Million at the End of 2020

FEATURED COMPANIES

  • Cellex Inc.
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Genematrix
  • Robert Bosch GmbH
  • Seegene Inc.

The global COVID-19 diagnostics market size is anticipated to reach $17,203.38 million till the end of 2020. COVID-19 is an infectious disease caused by a newly discovered Coronavirus with a nomenclature Sars Cov 2. The virus strain shows significant similarity with an earlier detected virus, Sars Cov. The virus outbreak started from Wuhan city of China and is now spread across 210 countries and territories around the world and 2 international conveyances, as per Worldometer data.

Significant increase in the incidences of COVID-19 across the globe and The rise in mortality rates due to the outbreak are the major factors that drive the market growth. Moreover, technological developments and introduction of various test kits by companies worldwide propels the market growth. However, dearth of diagnosis kits in developing economies is anticipated to hamper the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a fast pace.

KEY BENEFITS FOR STAKEHOLDERS


  • This report provides a detailed quantitative analysis of the current COVID-19 diagnostics market trends and forecast estimations from 2020 to 2022, which assists to identify the prevailing market opportunities.
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the COVID-19 market growth is provided.
  • The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2022, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook.

KEY MARKET SEGMENTS

By Product


  • PCR Kits
  • POC Kits
  • Immuno Assay

By Technology


  • Molecular
  • Immunoassay

By End-user


  • Hospitals
  • Physician's office and urgent care clinics
  • Diagnostic Labs

By Region


North America


  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe


  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Estonia
  • Austria
  • Czech Republic
  • Rest of Europe

Asia-Pacific


  • China
  • India
  • Australia
  • Japan
  • South Korea
  • Thailand
  • Malaysia
  • Rest of Asia-Pacific

LAMEA


  • Brazil
  • Saudi Arabia
  • South Africa
  • Israel
  • Rest of LAMEA

KEY MARKET PLAYERS


  • F. Hoffmann-La Roche AG
  • Seegene Inc.
  • Cepheid
  • MyLabLifeSolutions Pvt. Ltd.
  • SureScreen Diagnostics Ltd.
  • Thermo Fisher Scientific
  • Genematrix
  • Robert Bosch GmbH
  • Cellex
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cellex Inc.
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Genematrix
  • Robert Bosch GmbH
  • Seegene Inc.

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Porter's Five Forces Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Significant Increase in Incidences of COVID-19 Infection
3.3.1.2. Unavailability of Specific Medicines/Vaccines
3.3.2. Restraints
3.3.2.1. Lack of COVID-19 Diagnostic Kits
3.3.3. Opportunity
3.3.3.1. Growth Opportunities in Emerging Economies
3.4. Insights on Antigen-Based Testing
3.5. Market Share Analysis
Chapter 4: COVID-19 Diagnostics Market, by Technology
4.1. Overview
4.1.1. Approved COVID-19 Diagnostic Products
4.1.2. Market Size and Forecast, by Technology
4.2. Molecular Assay
4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast, by Region
4.3. Immunoassay/Serology
4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast, by Region
Chapter 5: COVID-19 Diagnostics Market, by Product
5.1. Overview
5.1.1. Market Size and Forecast, by Product
5.2. PCR Kits
5.2.1. Market Size and Forecast, by Region
5.3. Immunoassay Test
5.3.1. Market Size and Forecast, by Region
5.4. POC (Point-Of-Care) Test
5.4.1. Market Size and Forecast, by Region
Chapter 6: COVID-19 Diagnostics Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast, by End-user
6.2. Hospitals
6.2.1. Market Size and Forecast, by Region
6.3. Diagnostic Laboratories
6.3.1. Market Size and Forecast, by Region
6.4. Physician Offices & Urgent Care Clinics
6.4.1. Market Size and Forecast, by Region
Chapter 7: COVID-19 Diagnostics Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S. Market Size and Forecast, by Technology
7.2.2.2. U.S. Market Size and Forecast, by Product
7.2.2.3. U.S. Market Size and Forecast, by End-user
7.2.2.4. Canada Market Size and Forecast, by Technology
7.2.2.5. Canada Market Size and Forecast, by Product
7.2.2.6. Canada. Market Size and Forecast, by End-user
7.2.2.7. Mexico Market Size and Forecast, by Technology
7.2.2.8. Mexico Market Size and Forecast, by Product
7.2.2.9. Mexico. Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends
7.3.2. Market Size and Forecast, by Country
7.3.2.1. France Market Size and Forecast, by Technology
7.3.2.2. France Market Size and Forecast, by Product
7.3.2.3. France Market Size and Forecast, by End-user
7.3.2.4. UK Market Size and Forecast, by Technology
7.3.2.5. UK Market Size and Forecast, by Product
7.3.2.6. UK Market Size and Forecast, by End-user
7.3.2.7. Germany Market Size and Forecast, by Technology
7.3.2.8. Germany Market Size and Forecast, by Product
7.3.2.9. Germany Market Size and Forecast, by End-user
7.3.2.10. Spain Market Size and Forecast, by Technology
7.3.2.11. Spain Market Size and Forecast, by Product
7.3.2.12. Spain Market Size and Forecast, by End-user
7.3.2.13. Italy Market Size and Forecast, by Technology
7.3.2.14. Italy Market Size and Forecast, by Product
7.3.2.15. Italy Market Size and Forecast, by End-user
7.3.2.16. Austria Market Size and Forecast, by Technology
7.3.2.17. Austria Market Size and Forecast, by Product
7.3.2.18. Austria Market Size and Forecast, by End-user
7.3.2.19. Estonia Market Size and Forecast, by Technology
7.3.2.20. Estonia Market Size and Forecast, by Product
7.3.2.21. Estonia Market Size and Forecast, by End-user
7.3.2.22. Czech Republic Market Size and Forecast, by Technology
7.3.2.23. Czech Republic Market Size and Forecast, by Product
7.3.2.24. Czech Republic Market Size and Forecast, by End-user
7.3.2.25. Rest of Europe Market Size and Forecast, by Technology
7.3.2.26. Rest of Europe Market Size and Forecast, by Product
7.3.2.27. Rest of Europe Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.3.1. Japan Market Size and Forecast, by Technology
7.4.3.2. Japan Market Size and Forecast, by Product
7.4.3.3. Japan Market Size and Forecast, by End-user
7.4.3.4. China Market Size and Forecast, by Technology
7.4.3.5. China Market Size and Forecast, by Product
7.4.3.6. China Market Size and Forecast, by End-user
7.4.3.7. India Market Size and Forecast, by Technology
7.4.3.8. India Market Size and Forecast, by Product
7.4.3.9. India Market Size and Forecast, by End-user
7.4.3.10. Australia Market Size and Forecast, by Technology
7.4.3.11. Australia Market Size and Forecast, by Product
7.4.3.12. Australia Market Size and Forecast, by End-user
7.4.3.13. South Korea Market Size and Forecast, by Technology
7.4.3.14. South Korea Market Size and Forecast, by Product
7.4.3.15. South Korea Market Size and Forecast, by End-user
7.4.3.16. Thailand Market Size and Forecast, by Technology
7.4.3.17. Thailand Market Size and Forecast, by Product
7.4.3.18. Thailand Market Size and Forecast, by End-user
7.4.3.19. Malaysia Market Size and Forecast, by Technology
7.4.3.20. Malaysia Market Size and Forecast, by Product
7.4.3.21. Malaysia Market Size and Forecast, by End-user
7.4.3.22. Rest of Asia-Pacific Market Size and Forecast, by Technology
7.4.3.23. Rest of Asia-Pacific Market Size and Forecast, by Product
7.4.3.24. Rest of Asia-Pacific Market Size and Forecast, by End-user
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Brazil Market Size and Forecast, by Technology
7.5.2.2. Brazil Market Size and Forecast, by Product
7.5.2.3. Brazil Market Size and Forecast, by End-user
7.5.2.4. South Africa Market Size and Forecast, by Technology
7.5.2.5. South Africa Market Size and Forecast, by Product
7.5.2.6. South Africa Market Size and Forecast, by End-user
7.5.2.7. Saudi Arabia Market Size and Forecast, by Technology
7.5.2.8. Saudi Arabia Market Size and Forecast, by Product
7.5.2.9. Saudi Arabia Market Size and Forecast, by End-user
7.5.2.10. Israel Market Size and Forecast, by Technology
7.5.2.11. Israel Market Size and Forecast, by Product
7.5.2.12. Israel Market Size and Forecast, by End-user
7.5.2.13. Rest of LAMEA Market Size and Forecast, by Technology
7.5.2.14. Rest of LAMEA Market Size and Forecast, by Product
7.5.2.15. Rest of LAMEA Market Size and Forecast, by End-user
Chapter 8: Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves and Developments
8.2. Cellex Incorporated
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Key Strategic Moves and Developments
8.3. Cepheid
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves and Developments
8.4. F. Hoffmann-La Roche Ltd.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance.
8.4.6. Key Strategic Moves and Developments
8.5. Hologic, Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves and Developments
8.6. Laboratory Corp of America Holdings
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves and Developments
8.7. MyLabDiscovery Solutions Pvt. Ltd.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Key Strategic Moves and Developments
8.8. Quest Diagnostics Incorporated
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves and Developments
8.9. Seegene Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Key Strategic Moves and Developments
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves and Developments
List of Tables
Table 01. Antigen-Based Test Kit and Manufacturers
Table 02. Approved COVID-19 Diagnostic Products
Table 03. COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 04. COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 05. COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 06. COVID-19 Diagnostics Market for Molecular Assay, by Region, 2020 ($Million)
Table 07. COVID-19 Diagnostics Market for Molecular Assay, by Region, 2021 ($Million)
Table 08. COVID-19 Diagnostics Market for Molecular Assay, by Region, 2022 ($Million)
Table 09. COVID-19 Diagnostics Market for Immunoassay, by Region, 2020 ($Million)
Table 10. COVID-19 Diagnostics Market for Immunoassay, by Region, 2021 ($Million)
Table 11. COVID-19 Diagnostics Market for Immunoassay, by Region, 2022 ($Million)
Table 12. COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 13. COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 14. COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 15. COVID-19 Diagnostics Market, for PCR Kits, by Region, 2020 ($Million)
Table 16. COVID-19 Diagnostics Market, for PCR Kits, by Region, 2021 ($Million)
Table 17. COVID-19 Diagnostics Market, for PCR Kits, by Region, 2022 ($Million)
Table 18. COVID-19 Diagnostics Market for Immunoassay Test, by Region, 2020 ($Million)
Table 19. COVID-19 Diagnostics Market, for Immunoassay Test, by Region, 2021 ($Million)
Table 20. COVID-19 Diagnostics Market, for Immunoassay Test, by Region, 2022 ($Million)
Table 21. COVID-19 Diagnostics Market for POC Test Kits, by Region, 2020 ($Million)
Table 22. COVID-19 Diagnostics Market, for POC Test Kits, by Region, 2021 ($Million)
Table 23. COVID-19 Diagnostics Market, for POC Test Kits, by Region, 2022 ($Million)
Table 24. COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 25. COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 26. COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 27. COVID-19 Diagnostics Market, for Hospitals, by Region, 2020 ($Million)
Table 28. COVID-19 Diagnostics Market, for Hospitals, by Region, 2021 ($Million)
Table 29. COVID-19 Diagnostics Market, for Hospitals, by Region, 2022 ($Million)
Table 30. COVID-19 Diagnostics Market, for Diagnostic Laboratories, by Region, 2020 ($Million)
Table 31. COVID-19 Diagnostics Market, for Diagnostic Laboratories, by Region, 2021 ($Million)
Table 32. COVID-19 Diagnostics Market, for Diagnostic Laboratories, by Region, 2022 ($Million)
Table 33. COVID-19 Diagnostics Market, for Physician Offices & Urgent Care Clinics, by Region, 2020 ($Million)
Table 34. COVID-19 Diagnostics Market, for Physician Offices & Urgent Care Clinics, by Region, 2021 ($Million)
Table 35. COVID-19 Diagnostics Market, for Physician Offices & Urgent Care Clinics, by Region, 2022 ($Million)
Table 36. COVID-19 Diagnostics Market, by Region, 2020-2022 ($Million)
Table 37. COVID-19 Diagnostics Market, by Region, 2020-2022 (Number of Tests)
Table 38. North America COVID-19 Diagnostics Market, by Country, 2020 ($Million)
Table 39. North America COVID-19 Diagnostics Market, by Country, 2020 (Number of Tests)
Table 40. North America COVID-19 Diagnostics Market, by Country, 2021 ($Million)
Table 41. North America COVID-19 Diagnostics Market, by Country, 2021 (Number of Tests)
Table 42. North America COVID-19 Diagnostics Market, by Country, 2022 ($Million)
Table 43. North America COVID-19 Diagnostics Market, by Country, 2022 (Number of Tests)
Table 44. U.S. COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 45. U.S. COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 46. U.S. COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 47. U.S. COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 48. U.S. COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 49. U.S. COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 50. U.S. COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 51. U.S. COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 52. U.S. COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 53. Canada COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 54. Canada COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 55. Canada COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 56. Canada COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 57. Canada COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 58. Canada COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 59. Canada COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 60. Canada COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 61. Canada COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 62. Mexico COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 63. Mexico COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 64. Mexico COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 65. Mexico COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 66. Mexico COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 67. Mexico COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 68. Mexico COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 69. Mexico COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 70. Mexico COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 71. Europe COVID-19 Diagnostics Market, by Country, 2020 ($Million)
Table 72. Europe COVID-19 Diagnostics Market, by Country, 2020 (Number of Tests)
Table 73. Europe COVID-19 Diagnostics Market, by Country, 2021 ($Million)
Table 74. Europe COVID-19 Diagnostics Market, by Country, 2021 (Number of Tests)
Table 75. Europe COVID-19 Diagnostics Market, by Country, 2022 ($Million)
Table 76. Europe COVID-19 Diagnostics Market, by Country, 2021 (Number of Tests)
Table 77. France COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 78. France COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 79. France COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 80. France COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 81. France COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 82. France COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 83. France COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 84. France COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 85. France COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 86. UK COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 87. UK COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 88. UK COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 89. UK COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 90. UK COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 91. UK COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 92. UK COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 93. UK COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 94. UK Diagnostics Market, by End-user, 2022 ($Million)
Table 95. Germany COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 96. Germany COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 97. Germany COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 98. Germany COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 99. Germany COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 100. Germany COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 101. Germany COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 102. Germany COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 103. Germany COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 104. Spain COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 105. Spain COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 106. Spain COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 107. Spain COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 108. Spain COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 109. Spain COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 110. Spain COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 111. Spain COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 112. Spain COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 113. Italy COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 114. Italy COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 115. Italy COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 116. Italy COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 117. Italy COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 118. Italy COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 119. Italy COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 120. Italy COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 121. Italy COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 122. Austria COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 123. Austria COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 124. Austria COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 125. Austria COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 126. Austria COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 127. Austria COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 128. Austria COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 129. Austria COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 130. Austria COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 131. Estonia COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 132. Estonia COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 133. Estonia COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 134. Estonia COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 135. Estonia COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 136. Estonia COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 137. Estonia COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 138. Estonia COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 139. Estonia COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 140. Czech Republic COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 141. Czech Republic COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 142. Czech Republic COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 143. Czech Republic COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 144. Czech Republic COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 145. Czech Republic COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 146. Czech Republic COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 147. Czech Republic COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 148. Czech Republic COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 149. Rest of Europe COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 150. Rest of Europe COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 151. Rest of Europe COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 152. Rest of Europe COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 153. Rest of Europe COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 154. Rest of Europe COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 155. Rest of Europe COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 156. Rest of Europe COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 157. Rest of Europe COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 158. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2020($Million)
Table 159. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2020 (Number of Tests)
Table 160. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2021($Million)
Table 161. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2021 (Number of Tests)
Table 162. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2022($Million)
Table 163. Asia-Pacific COVID-19 Diagnostics Market, by Country, 2022 (Number of Tests)
Table 164. Japan COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 165. Japan COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 166. Japan COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 167. Japan COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 168. Japan COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 169. Japan COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 170. Japan COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 171. Japan COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 172. Japan COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 173. China COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 174. China COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 175. China COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 176. China COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 177. China COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 178. China COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 179. China Diagnostics Market, by End-user, 2020 ($Million)
Table 180. China COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 181. China COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 182. India COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 183. India COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 184. India COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 185. IndiaCOVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 186. India COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 187. India COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 188. India COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 189. India COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 190. India COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 191. Australia COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 192. Australia COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 193. Australia Market, by Technology, 2022 ($Million)
Table 194. Australia COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 195. Australia COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 196. Australia COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 197. Australia COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 198. Australia COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 199. Australia COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 200. South Korea COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 201. South Korea COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 202. South Korea COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 203. South Korea COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 204. South Korea COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 205. South Korea COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 206. South Korea COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 207. South KoreaCOVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 208. South Korea COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 209. Thailand COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 210. Thailand COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 211. Thailand COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 212. Thailand COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 213. Thailand COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 214. Thailand COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 215. Thailand COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 216. Thailand COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 217. Thailand COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 218. Malaysia COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 219. Malaysia COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 220. Malaysia COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 221. Malaysia COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 222. Malaysia COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 223. Malaysia COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 224. Malaysia COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 225. Malaysia COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 226. Malaysia COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 227. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 228. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 229. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 230. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 231. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 232. Rest of Asia-Pacific COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 233. Rest of Asia-Pacific COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 234. Rest of Asia-Pacific COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 235. Rest of Asia-Pacific COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 236. LAMEA COVID-19 Diagnostics Market, by Country, 2020 ($Million)
Table 237. LAMEA COVID-19 Diagnostics Market, by Country, 2020(Number of Tests)
Table 238. LAMEA COVID-19 Diagnostics Market, by Country, 2021 ($Million)
Table 239. LAMEA COVID-19 Diagnostics Market, by Country, 2021(Number of Tests)
Table 240. LAMEA COVID-19 Diagnostics Market, by Country, 2022 ($Million)
Table 241. LAMEA COVID-19 Diagnostics Market, by Country, 2022(Number of Tests)
Table 242. Brazil COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 243. Brazil COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 244. Brazil COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 245. Brazil COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 246. Brazil COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 247. Brazil COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 248. Brazil COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 249. Brazil COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 250. Brazil COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 251. South Africa COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 252. South Africa COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 253. South Africa COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 254. South Africa COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 255. South Africa COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 256. South Africa COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 257. South Africa COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 258. South Africa COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 259. South Africa COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 260. Saudi Arabia COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 261. Saudi Arabia COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 262. Saudi Arabia COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 263. Saudi Arabia COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 264. Saudi Arabia COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 265. Saudi Arabia COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 266. Saudi Arabia COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 267. Saudi Arabia COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 268. Saudi Arabia COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 269. Israel COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 270. Israel COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 271. Israel COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 272. Israel COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 273. Israel COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 274. Israel COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 275. Israel COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 276. Israel COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 277. Israel COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 278. Rest of LAMEA COVID-19 Diagnostics Market, by Technology, 2020 ($Million)
Table 279. Rest of LAMEA COVID-19 Diagnostics Market, by Technology, 2021 ($Million)
Table 280. Rest of LAMEA COVID-19 Diagnostics Market, by Technology, 2022 ($Million)
Table 281. Rest of LAMEA COVID-19 Diagnostics Market, by Product, 2020 ($Million)
Table 282. Rest of LAMEA COVID-19 Diagnostics Market, by Product, 2021 ($Million)
Table 283. Rest of LAMEA COVID-19 Diagnostics Market, by Product, 2022 ($Million)
Table 284. Rest of LAMEA COVID-19 Diagnostics Market, by End-user, 2020 ($Million)
Table 285. Rest of LAMEA COVID-19 Diagnostics Market, by End-user, 2021 ($Million)
Table 286. Rest of LAMEA COVID-19 Diagnostics Market, by End-user, 2022 ($Million)
Table 287. Abbott: Company Snapshot
Table 288. Abbott: Operating Segment
Table 289. Abbott: Product Portfolio
Table 290. Abbott: Key Strategic Moves and Developments
Table 291. Cellex: Company Snapshot
Table 292. Cellex: Operating Segments
Table 293. Cellex: Product Portfolio
Table 294. Cellex: Key Strategic Moves and Developments
Table 295. Cepheid: Company Snapshot
Table 296. Cepheid: Operating Business Segments
Table 297. Cepheid: Product Portfolio
Table 298. Roche: Company Snapshot
Table 299. Roche: Operating Segments
Table 300. Roche: Product Portfolio
Table 301. Hologic: Company Snapshot
Table 302. Hologic: Operating Business Segments
Table 303. Hologic: Product Portfolio
Table 304. Labcorp: Company Snapshot
Table 305. Labcorp: Operating Segments
Table 306. Labcorp: Product Portfolio
Table 307. Mylab: Company Snapshot
Table 308. Mylab: Product Segments
Table 309. Mylab: Product Portfolio
Table 310. Quest Diagnostics: Company Snapshot
Table 311. Quest Diagnostics: Operating Business Segments
Table 312. Quest: Product Portfolio
Table 313. Seegene: Company Snapshot
Table 314. Seegene: Operating Segments
Table 315. Seegene: Product Portfolio
Table 316. Thermo Fisher Scientific.: Company Snapshot
Table 317. Thermo Fisher Scientific: Product Segments
Table 318. Thermo Fisher Scientific: Product Portfolio
List of Figures
Figure 01. COVID-19 Diagnostics Market Segmentation
Figure 02. Low Bargaining Power of Suppliers
Figure 03. Low Bargaining Power of Buyers
Figure 04. Moderate Threat of Substitutes
Figure 05. Low-To-Moderate Threat of New Entrants
Figure 06. High Competitive Rivalry
Figure 07. Drivers and Restraints
Figure 08. Market Share Analysis, Molecular Kits
Figure 09. Market Share Analysis, Immunoassay Test
Figure 10. Market Share Analysis, Molecular Point of Care Kits
Figure 11. Market Share Analysis, North America Molecular Kits
Figure 12. Market Share Analysis, North America Immunoassay Test
Figure 13. Market Share Analysis, North America Molecular Point of Care Kits
Figure 14. Market Share Analysis, Europe Molecular Kits
Figure 15. Market Share Analysis, Europe Immunoassay Test
Figure 16. Market Share Analysis, Europe Molecular Point of Care Kits
Figure 17. Market Share Analysis, Asia-Pacific Molecular Kits (RT PCR)
Figure 18. Market Share Analysis, Asia-Pacific Immunoassay Test
Figure 19. Market Share Analysis, Asia-Pacific Molecular Point of Care Kits
Figure 20. Market Share Analysis, LAMEA Molecular Kits
Figure 21. Market Share Analysis, LAMEA Immunoassay Test
Figure 22. Market Share Analysis, LAMEA Molecular Point of Care Kits
Figure 23. Abbott: Net Sales, 2017-2019 ($Million)
Figure 24. Abbott: Revenue Share by Segment, 2019 (%)
Figure 25. Abbott: Revenue Share, by Region, 2019(%)
Figure 26. Roche: Net Sales, 2017-2019 ($Million)
Figure 27. Roche: Revenue Share by Segment, 2019 (%)
Figure 28. Roche: Revenue Share by Region, 2019 (%)
Figure 29. Hologic: Net Sales, 2017-2019 ($Million)
Figure 30. Hologic: Revenue Share by Segment, 2019 (%)
Figure 31. Hologic: Revenue Share by Region, 2019 (%)
Figure 32. Labcorp: Net Sales, 2017-2019 ($Million)
Figure 33. Labcorp: Revenue Share by Segment, 2019 (%)
Figure 34. Labcorp: Revenue Share by Region, 2019 (%)
Figure 35. Quest Diagnostics: Net Sales, 2017-2019 ($Million)
Figure 36. Quest Diagnostics: Revenue Share by Segment, 2019 (%)
Figure 37. Thermo Fisher Scientific, Inc. : Net Sales, 2017-2019 ($Million)
Figure 38. Thermo Fisher Scientific, Inc. : Revenue Share by Segment, 2019 (%)
Figure 39. Thermo Fisher Scientific. Revenue Share by Region, 2019 (%)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cellex Inc.
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Genematrix
  • Robert Bosch GmbH
  • Seegene Inc.
According to the report titled, 'Covid-19 Diagnostics Market by Product, Technology, and End User: Opportunity Analysis and Industry Forecast, 2020-2022' the global Covid-19 Diagnostics market size is anticipated to reach $780 million by the end of 2020.

Covid-19 is an infectious disease caused by a novel coronavirus. The first ever human encounter of the virus was reported in December 2019 in Wuhan City of China. The virus responsible for the cause of the disease is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This nomenclature was chosen owing to the fact that the virus is genetically related to a type of coronavirus responsible for the SARS outbreak, which occurred in 2003. The Covid-19 outbreak was declared a pandemic by the World Health Organization (WHO), on March 11, 2020. The outbreak has spread in over 199 countries and territories across the globe. As per the WHO, till March, 30, 2020, there were a total of 722,196 positive cases of coronavirus COVID-19 and 33,976 deaths worldwide.

The major factors that drive the covid-19 diagnostics market growth include a significant increase in patient population across the globe, the immense need of rapid diagnostics and unavailability of specific medicine or a vaccine. However, lack of awareness among developing countries regarding the necessary precautions to be taken and dearth of diagnosis kits and medical professionals that have sufficient knowledge regarding the use of diagnostic kits for novel Covid-19 are the major factors anticipated to hamper market growth.

The covid-19 diagnostics market is segmented on the basis of product, technology, end-users, and region. By product, it is categorized into PCR Kits, POC (point of contact) Kits and immune-assay. By technology, it is segmented into PCR and immunoassay. By end-users it is segmented into hospitals, physician's office & urgent care clinics and diagnostic labs. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By technology, the Covid-19 diagnostics market is segregated into PCR and immunoassay. The PCR segment accounted for xx% of the total share in 2020 and is expected to exhibit a prominent growth rate in the near future, owing to its increased demand for diagnosis of coronavirus patients. In addition PCR is considered as a gold standard in terms of diagnosis of new virus infections. However, immunoassay segment is anticipated to grow at the fastest growth rate during the forecast period. This is attributed to the increased demand for rapid serological tests for disease diagnosis. Many serological kits are being developed for the confirmation of Sars Cov 2 infections. Thus, the sensors are purchased in bulk and very frequently by customers. Bulk purchase is preferred as the manufacturers offer a discount to the customers.

By end user, the diagnosis labs segment dominated the Covid-19 diagnostics market in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that PCR tests are mostly carried in a diagnosis laboratory.

According to Onkar Sumant, Manager, Healthcare at Allied Market Research, “Significant surge in the incidence of Sar Cov 2 infections across the globe and immense requirement of diagnosis kits to control the outbreak is the major factor propelling market growth of global covid-19 diagnostics market”

Key Findings of the Study:

The PCR segment will dominate the global covid-19 diagnostics market till the forecast period.
The immunoassay segment is projected to grow at a significant rate during the forecast period.
Based on end user, the diagnosis lab segment is anticipated to dominate the covid-19 diagnostics market throughout the forecast period.

Key companies working towards the development of rapid diagnostic kits for Covid-19 include F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd, Cellex Inc., Genematrix,. Thermo Fisher Scientific, Inc. and Robert Bosch GmbH among others.
Note: Product cover images may vary from those shown
  • F. Hoffmann-La Roche AG
  • Seegene Inc.
  • Cepheid
  • MyLabLifeSolutions Pvt. Ltd.
  • SureScreen Diagnostics Ltd.
  • Cellex Inc.
  • Genematrix
  • Thermo Fisher Scientific Inc.
  • Robert Bosch GmbH
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...